Evidence map›Paper›PMID 39400198›Full record

ArticleBrain : a journal of neurology2024

Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment.

Marvin Petersen, Mirthe Coenen, Charles DeCarli, Alberto De Luca, Ewoud van der Lelij, Alzheimer’s Disease Neuroimaging Initiative, Frederik Barkhof, Thomas Benke, Christopher P L H Chen, Peter Dal-Bianco and 32 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

Marvin PetersenDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20251Germany.ORCID 0000-0001-6426-7167
Mirthe CoenenDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Charles DeCarliDepartment of Neurology, University of California, Davis, CA 95616USA.
Alberto De LucaDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Ewoud van der LelijDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Alzheimer’s Disease Neuroimaging Initiative
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081 BT, The Netherlands.
Thomas BenkeClinic of Neurology, Medical University Innsbruck, Innsbruck 6020, Austria.
Christopher P L H ChenDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Peter Dal-BiancoDepartment of Neurology, Medical University Vienna, Vienna 1090, Austria.
Anna DewenterInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich 81377, Germany.ORCID 0000-0002-5636-196X
Marco DueringInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich 81377, Germany.ORCID 0000-0003-2302-3136
Christian EnzingerDivision of General Neurology, Department of Neurology, Medical University Graz, Graz 8036, Austria.
Michael EwersInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich 81377, Germany.ORCID 0000-0001-5231-1714
Lieza G ExaltoDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Evan M FletcherDepartment of Neurology, University of California, Davis, CA 95616USA.ORCID 0000-0002-9761-3131
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich 81377, Germany.ORCID 0000-0001-9736-2283
Saima HilalDepartment of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Edith HoferDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz 8036, Austria.
Huiberdina L KoekDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Andrea B MaierDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Pauline M MaillardDepartment of Neurology, University of California, Davis, CA 95616USA.
Cheryl R McCrearyDepartment of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary AB T2N 4N1, Canada.
Janne M PapmaAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam 3015 GD, The Netherlands.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081 BT, The Netherlands.
Reinhold SchmidtDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz 8036, Austria.
Eric E SmithDepartment of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary AB T2N 4N1, Canada.
Rebecca M E SteketeeAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081 BT, The Netherlands.
Esther van den BergAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam 3015 GD, The Netherlands.
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081 BT, The Netherlands.
Vikram VenkatraghavanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081 BT, The Netherlands.ORCID 0000-0001-9759-0462
Narayanaswamy VenketasubramanianMemory, Aging and Cognition Center, National University Health System, Singapore 119228, Singapore.
Meike W VernooijAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam 3015 GD, The Netherlands.ORCID 0000-0003-4658-2176
Frank J WoltersDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam 3015 GD, The Netherlands.
Xin XuMemory, Aging and Cognition Center, National University Health System, Singapore 119228, Singapore.
Andreas HornDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Movement Disorders and Neuromodulation Unit, Berlin 10117, Germany.
Kaustubh R PatilInstitute for Systems Neuroscience, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf 40225, Germany.
Simon B EickhoffInstitute for Systems Neuroscience, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf 40225, Germany.ORCID 0000-0001-6363-2759
Götz ThomallaDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20251Germany.ORCID 0000-0002-4785-1449
J Matthijs BiesbroekDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.ORCID 0000-0001-7017-2148
Geert Jan BiesselsDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht 3584 CX, The Netherlands.
Bastian ChengDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20251Germany.ORCID 0000-0003-2434-1822

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Carolyn Wei Zhu · 2020 to 2026
$31.0M
Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Alzheimer's Disease Neuroimaging InitiativeDeutsche Forschungsgemeinschaft 2041-454012190NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG066514NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG072972NIA NIH HHS P30 AG072979NIA NIH HHS U01 AG024904NIBIB NIH HHSNIH HHS U01 AG024904Northern California Institute for Research and EducationUniversity of Southern CaliforniaVici 918.16.616
6 · The paper itself

Abstract

White matter hyperintensities of presumed vascular origin (WMH) are associated with cognitive impairment and are a key imaging marker in evaluating brain health. However, WMH volume alone does not fully account for the extent of cognitive deficits and the mechanisms linking WMH to these deficits remain unclear. Lesion network mapping (LNM) enables us to infer if brain networks are connected to lesions and could be a promising technique for enhancing our understanding of the role of WMH in cognitive disorders. Our study employed LNM to test the following hypotheses: (i) LNM-informed markers surpass WMH volumes in predicting cognitive performance; and (ii) WMH contributing to cognitive impairment map to specific brain networks. We analysed cross-sectional data of 3485 patients from 10 memory clinic cohorts within the Meta VCI Map Consortium, using harmonized test results in four cognitive domains and WMH segmentations. WMH segmentations were registered to a standard space and mapped onto existing normative structural and functional brain connectome data. We employed LNM to quantify WMH connectivity to 480 atlas-based grey and white matter regions of interest (ROI), resulting in ROI-level structural and functional LNM scores. We compared the capacity of total and regional WMH volumes and LNM scores in predicting cognitive function using ridge regression models in a nested cross-validation. LNM scores predicted performance in three cognitive domains (attention/executive function, information processing speed, and verbal memory) significantly better than WMH volumes. LNM scores did not improve prediction for language functions. ROI-level analysis revealed that higher LNM scores, representing greater connectivity to WMH, in grey and white matter regions of the dorsal and ventral attention networks were associated with lower cognitive performance. Measures of WMH-related brain network connectivity significantly improve the prediction of current cognitive performance in memory clinic patients compared to WMH volume as a traditional imaging marker of cerebrovascular disease. This highlights the crucial role of network integrity, particularly in attention-related brain regions, improving our understanding of vascular contributions to cognitive impairment. Moving forward, refining WMH information with connectivity data could contribute to patient-tailored therapeutic interventions and facilitate the identification of subgroups at risk of cognitive disorders.

Indexed as

Magnetic Resonance ImagingWhite MatterAgedBrainCognitionCognitive DysfunctionConnectomeCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeuropsychological Testscerebral small vessel diseasedementialesion network mappingmagnetic resonance imagingvascular cognitive impairmentwhite matter hyperintensities

Identifiers

PMID39400198
PMCPMC11629703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.